<DOC>
	<DOCNO>NCT02626741</DOCNO>
	<brief_summary>The purpose study determine whether meal replacement , SlimWell Â® , effective treatment obesity patient metabolic syndrome .</brief_summary>
	<brief_title>Effect Meal Replacement Weight Loss Obesity Patients With Metabolic Syndrome</brief_title>
	<detailed_description>The participant divide two group : intervention group control group . In intervention group , participant receive meal replacement plus life style modification . In control group , participant receive life style modification . Sample size calculation 69 participant per group . Primary outcome compare weight loss intervention group control group .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Obesity , Abdominal</mesh_term>
	<criteria>Body mass index equal 25 kg/m2 Patients metabolic syndrome Patients antihypertensive drug , oral hypoglycemic drug lipid lower drug . Uncontrolled diabetes patient Patients gastrointestinal abnormality Patients cardiovascular disease Patients hematologic disorder Patients Glomerular filtration rate le 60 ml/min/1.73m2 Patients drug alcohol abuse Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>